AI assistant
Coloplast — Major Shareholding Notification 2010
Apr 13, 2010
3358_mrq_2010-04-13_0bd358a4-8974-43f6-8870-0045a37ef4f9.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Announcement No. 4/2010 13 April 2010
Major shareholder announcement
Pursuant to announcements Nos. 14/2008 of 14 August 2008 and 21/2009 of 4 December 2009 major shareholder Niels Peter Louis-Hansen hereby announces his policy regarding his shareholding in Coloplast A/S:
If necessary, Niels Peter Louis-Hansen will participate in Coloplast A/S' share buy-back programmes or convert A shares into B shares to ensure that his share of votes will not exceed 45%.
Niels Peter Louis-Hansen today holds 40.38% of the votes through his holding of nom. DKK 12,285,000 A shares and nom. DKK 19,676,250 B shares in Coloplast A/S.
The announced policy will be revised and communicated, if the present legal regime should be changed, if owners of A-shares should transfer shares amongst themselves, or if Niels Peter Louis-Hansen should receive a significant portion of shares by gift or inheritance. Niels Peter Louis-Hansen will in any event in 2016 decide whether this policy should be revised.
This announcement is made in Danish and in English. In the event of discrepancies, the Danish version shall prevail.
Signed Niels Peter Louis-Hansen
Lene Skole Executive Vice President, CFO
For further information, please contact
Investors and analysts
Lene Skole Executive Vice President, CFO Tel. +45 4911 1700
Ian S.E. Christensen Director of Investor Relations Tel. +45 4911 1800/+45 4911 1301 Email: [email protected]
Press and the media
Morten Sørensen Media Relations Manager Tel. +45 4911 2632 Email: [email protected]
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2010-04 All rights reserved. Coloplast A/S, 3050 Humlebæk, Denmark.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.
Our business includes Ostomy Care, Urology and Continence Care and Wound and Skin Care. We operate globally and employ more than 7,000 people.